Module 1: From Bench to Bedside
Authors: Adi Achanta; Stephanie Alden; Pamela Chen; Ziqi Chen; Sunny Chung; Ayooluwa Douglas; Jack Ghannam; Nicole M. Gilette; Jasmin Joseph-Chazan; Ashwini Joshi; Pinky Langat, PhD; Rebecca Larson; Yuzhong Jeff Meng, PhD; Adam Nitido; Blake Oberfeld; Jordan Said; Suparna Kumar; Rifat Rahman; Simone Sasse; Abigail Schiff, PhD; Allen Zhou
Editor: Kendall Carpenter
Reviewers: Gaurav Gaiha, MD, PhD; Daniel Solomon, MD; Shiv Pillai, MD, PhD
Highlight of Updates (1/22/21):
New discussion of COVID-19 variants
Updated vaccine development table
The Coronavirus Disease 2019 (COVID-19) pandemic has had massive, overarching ramifications for our global population. This is an unprecedented time for our healthcare system, and as medical trainees ourselves, we felt an obligation to synthesize the growing literature and educate our peers.
This first module, written by students for students, is designed to walk you through the disease characteristics of COVID-19, including the basic virology of SARS-CoV-2 (the etiologic agent of COVID-19) and clinical knowledge to date. We hope that a deeper understanding of the pathophysiology of the virus, including its structure, transmission, and host immune defenses, will allow you to critically engage with evolving diagnosis, treatment, and prevention efforts. Throughout, we will highlight areas of ongoing investigation and innovation, from bench to bedside. We expect that this module will take 2.5-3 hours to complete.
At the end of this module, medical students should be able to:
Relate the basic virology of SARS-CoV-2 to evolving COVID-19 diagnosis and prevention approaches
Translate knowledge of the host immune response against SARS-CoV-2 to COVID-19 risk stratification, treatment, and vaccine strategies
Build a differential diagnosis for COVID-19 using its typical clinical manifestations, laboratory, and imaging findings
Evaluate current triage and treatment recommendations for COVID-19, stratified by disease severity
Appreciate how COVID-19 pathophysiology underlies ongoing research into investigational therapeutics and vaccines
